Osteoarthritis (OA), a common skeletal disease, is a leading cause of disability among the elderly populations. OA is characterized by gradual loss of articular cartilage, but the etiology and pathogenesis of OA are largely unknown. Epidemiological and genetic studies have demonstrated that genetic factors play an important role in OA. To identify susceptibility genes for OA, we performed a large-scale, case -control association study using gene-based single nucleotide polymorphisms (SNPs). In two independent casecontrol populations, we found significant association (P 5 9.8 3 10 27 ) between hip OA and a SNP (IVS3 2 293C > T) located in intron 3 of the calmodulin (CaM) 1 gene (CALM1 ). CALM1 was expressed in cultured chondrocytes and articular cartilage, and its expression was increased in OA. Subsequent linkage-disequilibrium mapping identified five SNPs showing significant association equivalent to IVS3 2 293C > T. One of these (216C > T) is located in the core promoter region of CALM1. Functional analyses indicate that the susceptibility 216T allele decreases CALM1 transcription in vitro and in vivo. Inhibition of CaM in chondrogenic cells reduced the expression of the major cartilage matrix genes Col2a1 and Agc1. These results suggest that the transcriptional level of CALM1 is associated with susceptibility for hip OA through modulation of chondrogenic activity. Our findings reveal the CALM1-mediated signaling pathway in chondrocytes as a novel potential target for treatment of OA.
Osteoarthritis (OA), a common skeletal disease, is a leading cause of disability among the elderly populations. OA is characterized by gradual loss of articular cartilage, but the etiology and pathogenesis of OA are largely unknown. Epidemiological and genetic studies have demonstrated that genetic factors play an important role in OA. To identify susceptibility genes for OA, we performed a large-scale, case -control association study using gene-based single nucleotide polymorphisms (SNPs). In two independent casecontrol populations, we found significant association (P 5 9.8 3 10 27 ) between hip OA and a SNP (IVS3 2 293C > T) located in intron 3 of the calmodulin (CaM) 1 gene (CALM1 ). CALM1 was expressed in cultured chondrocytes and articular cartilage, and its expression was increased in OA. Subsequent linkage-disequilibrium mapping identified five SNPs showing significant association equivalent to IVS3 2 293C > T. One of these (216C > T) is located in the core promoter region of CALM1. Functional analyses indicate that the susceptibility 216T allele decreases CALM1 transcription in vitro and in vivo. Inhibition of CaM in chondrogenic cells reduced the expression of the major cartilage matrix genes Col2a1 and Agc1. These results suggest that the transcriptional level of CALM1 is associated with susceptibility for hip OA through modulation of chondrogenic activity. Our findings reveal the CALM1-mediated signaling pathway in chondrocytes as a novel potential target for treatment of OA. 
INTRODUCTION
Osteoarthritis (OA; MIM165720) is a common disease and a leading cause of disability among the elderly populations. OA causes pain, deformity and loss of joint function, leading to reduced activity in daily living and decreased quality of life. OA affects various joints, most commonly spine, hand, knee and hip, with clinical features that are unique to each joint. About 20 million patients suffer from OA in the United States (1) , and in Japan, the prevalence of hip OA has been reported as 3.5% (women) and 1.4% (men) (2) . The cost of OA to society is estimated to exceed $15 billion in the United States, an amount roughly three times that of rheumatoid arthritis (3) . Thus, OA is a serious medical and economical issue, particularly in the aging populations of developed countries.
OA is a degenerative disease characterized by gradual loss of articular cartilage. During the course of life, articular cartilage is lost gradually because of excessive mechanical stress and/or injuries to the joint. Decompensation of the capacity for cartilage repair by chondrocytes has been suggested as potential pathogenic factor in OA (4) . In addition, aberration of cartilage matrix metabolism ultimately results in failure of its ability to respond to and withstand mechanical stress on the joint and hence contributing to OA.
The etiology and pathogenesis of OA remain largely undetermined. Epidemiological studies have demonstrated that OA is a genetic disease, with its major component transmitted as a complex, multifactorial trait (5). Many genetic studies have sought to identify susceptibility genes for OA, including candidate gene association studies and genome-wide linkage studies of hand, knee and hip OA (6 -8) . These efforts have resulted in the identification of several susceptibility loci for each type of OA, confirming that OA has a genetic component. However, the genetic components of OA remain largely uncharacterized because of limitations in current genetic approaches. Candidate gene association studies are severely limited by the requirement for a priori knowledge of 'candidacy'. The utility of linkage studies is limited by the fact that defined genomic regions, which contain hundreds of genes, are very broad to pinpoint single disease genes. Alternative methods for identifying susceptibility genes in common disease include the genome-wide association study, followed by linkagedisequilibrium (LD) mapping using single nucleotide polymorphisms (SNPs). This approach has been used successfully to identify susceptibility genes for myocardial infarction (9) .
Through a large-scale association study followed by LD mapping, we show that the calmodulin (CaM) 1 gene (CALM1 ) is associated with hip OA in the Japanese population. We identified a functional SNP in the core promoter region of CALM1, which affects transcription of the gene through varying affinity for nuclear protein(s). Inhibition of CaM by specific antagonists decreases expression of the major cartilage matrix genes in chondroprogenitor cells. Our findings indicate that CALM1 plays a crucial role in chondrocyte differentiation and that decreased CALM1 expression might contribute to OA.
RESULTS

Large-scale association study
To identify susceptibility loci for hip OA, we performed a large-scale, case -control association study using 94 individuals with hip OA and 633 control subjects (first screen). We were able to genotype 75 253 of 81 398 gene-based SNPs selected from the JSNP database. Among these, we tested the association of 71 880 SNPs that were in Hardy-Weinberg equilibrium. In each of four models (allelic and genotypic frequencies in both recessive and dominant models), 2219 SNPs had P-values less than 0.01. The results were similar to those of a previous study that identified a susceptibility gene for myocardial infarction using the same approach (9) . We then genotyped the qualifying SNPs from the first screen in a replication panel consisting of 334 individuals with hip OA and 375 control subjects and tested again for association. These independent tests identified several SNPs highly associated with hip OA (Mabuchi et al., manuscript in preparation). Among these was a SNP (IVS3 2 293C . T) in intron 3 of CALM1 on chromosome 14q24-q31. Association of the SNP was most significant in the recessive model ('TT' versus other genotypes) ( Table 1 ). The association was significant in both male and female sub-populations (Supplementary Material, Table S1 ). When association was tested by stratifying the cases into sub-populations with/without acetabular dysplasia, each sub-population showed significant association. The significance was higher in the cases without acetabular dysplasia (P ¼ 0.000033). The frequency of 'TT' genotype differed between the populations, but the difference was not statistically significant (P ¼ 0.19). The association was not found in knee OA (data not shown).
To localize the susceptibility gene present in this region, we evaluated the LD extension with IVS3 2 293C.T. We genotyped 334 individuals with hip OA for SNPs in the 400 kb region around IVS3 2 293C.T, then examined the LD index (D 0 ) between IVS3 2 293C.T and SNPs having allele frequencies .10%. All SNPs showing D 0 scores greater than 0.99 were localized within CALM1, indicating that the LD extension with IVS3 2 293C.T was limited to this gene (Fig. 1A) .
Expression analyses of CALM1
CALM1 encodes CaM, a ubiquitous eukaryotic calciumbinding protein, which is a principal mediator of the calcium signal (10) . CaM participates in cartilage metabolism in response to mechanical stimulation (11) . We found that CALM1 was expressed in human articular chondrocytes in alginate bead culture and in human articular cartilage from OA patients (Supplementary Material, Fig. S1A ). Microarray analysis showed higher levels of CALM1 expression in hip and knee OA cartilage than in normal cartilage (Supplementary Material, Fig. S1B and C) , further implicating CALM1 in OA pathogenesis.
Search for susceptibility SNP
To identify a susceptibility SNP in the genomic region of CALM1, we examined SNPs for all exons of CALM1, their 5 0 and 3 0 flanking sequences and a 1.4 kb promoter region using DNA from 16 hip OA patients. Within the CALM1 region, we confirmed a total of 21 SNPs (Fig. 1B) . We genotyped and divided the SNPs that were in absolute LD relationship with each other (pairwise LD index, D . 0.97) into eight groups (Supplementary Material, Table S2 ). For each SNP group with minor allele frequencies .10%, we genotyped representative SNPs in 334 case and 375 control individuals and analyzed the haplotype structure of the region. This analysis identified four common haplotypes, which covered .90% of the population haplotypes in both groups (Table 2) . For each haplotype, we examined the association with hip OA and found a significant association with haplotype II (Table 2 ). This haplotype contained only group D SNPs, represented by the original marker SNP, IVS3 2 293C.T (SNP 13 in Fig. 1B ). No other haplotype had a P-value lower than haplotype II. Moreover, three SNPs not included in the haplotype analyses (SNPs 14, 16 and 17 in Fig. 1B ) showed no significant association in the same case -control population (data not shown). Therefore, we concluded that the association with susceptibility to hip OA originated from the group D SNPs. We confirmed that all five SNPs in group D had significant association equivalent to IVS3 2 293C.T ( Table 3 ), indicating that these SNPs are all candidate susceptibility SNPs for hip OA. The P-value of the haplotype association is less than those of respective SNPs. Therefore, the possibility that the haplotype II itself is implicated in OA susceptibility is unlikely.
In vitro functional analyses of the susceptibility SNP located on the promoter region
One of the five candidate susceptibility SNPs, 216C.T (SNP 2 in Fig. 1B ), was localized within a core promoter region of CALM1, which includes the TATA element. To investigate possible allelic differences in promoter activity generated by this SNP, we generated fusion constructs which express the luciferase gene under the control of a 1.4 kb segment of CALM1 (nucleotides 21231 to þ202, shown in the left panel of Fig. 2B ) that has previously been reported to have promoter activity (12) . Reporter constructs containing the 216C or 216T allele were transfected in parallel into the OUMS-27 cells or Huh-7 cells. OUMS-27 cells are derived from a human chondrosarcoma and retain differentiated chondrocytic phenotypes (13); Huh-7 cells are derived from a hepatocellular carcinoma (14) . In OUMS-27 cells, the construct containing the 216C allele showed .2-fold luciferase activity than that containing the 216T allele ( Fig. 2A) . Similar results were observed in Huh-7 cells (Fig. 2B, top) . To investigate the critical region responsible for differences in transcriptional activity between the 216C and 216T alleles, we generated three deletion mutants of the CALM1 promoter construct. Approximately 2-fold differences in luciferase activity between the two alleles were observed with each construct, including the shortest 61 bp construct (nucleotides 253 to þ8), in Huh-7 cells (Fig. 2B) . These results indicate that the difference in transcriptional activity results from the sequence immediately surrounding the SNP.
Using a gel-shift assay, we examined whether a nuclear extract from Huh-7 cells could bind to the sequence surrounding 216C.T (Fig. 2C) . The band corresponding to the 216T allele was more intense than that corresponding to the 216C allele, indicating that one or more nuclear factors bound to the 216T allele more tightly than to the 216C allele. Taken together with the reduced transcriptional activity of the 216T allele relative to the 216C allele, this result suggests the presence of suppressor(s) of CALM1 transcription, which bind more tightly to the 216T allele.
Allelic differences in the expression of CALM1 in vivo
To investigate the effects of 216C.T on CALM1 transcription in vivo, we measured the amount of CALM1 transcripts under the control of each allele using RNA difference plot analysis (15) . Using fluorescence-labeled primers, we amplified cDNA and genomic DNA from the cells of an individual who was heterozygous with respect to 216C.T and evaluated the allelic difference of the linked marker in the transcribed region (þ114G.A in the 5 0 untranslated region, SNP 3 in Fig. 1B ). Molecular haplotyping confirmed the haplotype structures of 216 to þ114 as C -G and T -A. Original marker for which association was detected in the first screen. Amplified products were separated by electrophoresis specialized for polymerase chain reaction (PCR)-single-strand conformation polymorphism analysis, and the signal intensity of each allele was measured. The expression ratio of the þ114G to þ114A allele corresponding to that of 216C and 216T, respectively, was 1.09 (99% CI ¼ 1.04 -1.15). This result was replicated through a similar experiment using another marker (exon 7 þ 1996 G . C, SNP 20 in Fig. 1B ; the expression ratio: 1.12; 95% CI ¼ 1.05 -1.20). Thus, the susceptible 216T allele showed decreased in vivo expression levels relative to the non-susceptible 216C allele.
Role of CaM in chondrogenesis
To investigate the role of CaM in chondrogenesis, we used an in vitro chondrogenesis model, the ATDC5 cell line, which mimics chondrocyte differentiation in the presence of insulin (16) . During differentiation, the expression of Col2a1 and Agc1, which encode major cartilage extracellular matrix proteins, increased in a time-dependent manner ( Fig. 3A and B) .
Addition of the W-7, a naphthalene sulfonamide derivative which directly binds to and inhibits CaM, suppressed the expression of these genes by half ( Fig. 3A and B) . This observation indicates that CaM transduces one or more signals that induce expression of cartilage matrix genes during chondrocyte differentiation. To further investigate the role of CaM in chondrogenesis, we examined the effect of W-7 on Ca 2þ -regulated cartilage matrix gene expression in the rat chondrogenic cell line RCJ3.1C5.18. In these cells, expression of Col2a1 and Agc1 increased in the presence of ionomycin, a Ca 2þ ionophore that increases the intracellular concentration of Ca 2þ ( Fig. 3C and D) . These increases were suppressed by W-7 in a dose-dependent manner (Fig. 3C and D) . This observation indicated that the Ca 2þ signal induces cartilage matrix gene expression and is regulated by CaM in chondroprogenitor cells.
Analyses of combinatorial effect of CALM1 and other genes
To examine the relation of CALM1 to other genes in the etiology of hip OA, we estimated the combinatorial effect of CALM1 and other genes by combining genotype data on pair of loci in 323 cases and in 374 controls. We found significant combinatorial association between the CALM1 SNP and the asparatic acid repeat polymorphism (D14 allele) in the asporin gene (ASPN ) (17) , with regard to hip OA susceptibility. The two loci are not linked physically. The genotype that was homozygous with respect to the CALM1 allele and homozygous or heterozygous with respect to D14 allele in ASPN showed highest odds ratio (Table 4) .
DISCUSSION
Through a large-scale association study using SNPs and subsequent LD mapping, we have identified CALM1 as a susceptibility gene for hip OA. Multiple testing that might produce false-positive results is a considerable problem in large-scale association study because it uses a huge number of markers as in this study. The final P-value for the association of the SNP was calculated as 9.8 Â 10 27 by multiplying the P-values of the two independent tests. When Bonferroni's correction was applied to this result, we obtained only marginally significant association (the corrected P ¼ 0.070). Therefore, the possibility remains that the association of CALM1 might be false positive. However, it is widely recognized that Bonferroni's correction is overly conservative. If we exclude the makers that are in almost complete LD (D . 0.97) with others (n ¼ 19 794), the corrected P-value becomes 0.051. In addition to the association data, we have shown that CALM1 is expressed in normal articular cartilage, with increased expression in OA cartilage. CALM1 encodes CaM, which plays a crucial role in facilitating chondrocyte differentiation and maintaining the cartilage matrix. We have also shown that a SNP in the core promoter region of CALM1 exerts an allele-specific effect on gene expression in vitro and in vivo. These functional significances in cartilage and OA support the candidacy of CALM1 as a susceptibility gene for OA.
CaM binds to intracellular Ca 2þ and mediates various signals involved in cellular function including proliferation, motility, cell-cycle progression and transcription (10) . In chondroprogenitor cells, the Ca 2þ signal regulates chondrogenic differentiation. The elevation of intracellular concentration of Ca 2þ by ionomycin induces expression of Agc1 in the rat chondrogenic cell line RCJ3.1C5.18 (18) . Ionomycin also induces chondrogenesis in the limb bud mesenchyme of chicken (18) . Our experiments using W-7, specific antagonist of CaM, indicate that this signal is mediated by CaM. The crucial role of CaM in chondrogenic differentiation was also confirmed in ATDC5. Chondroprogenitor cells are present in human articular cartilage (19) and might be involved in cartilage repair. Decompensation of the cartilage repair capacity in chondrocyte function has been suggested as potential pathogenic factor for OA (4) . Therefore, aberration of the Ca 2þ -CaM signal regulating chondrogenesis over time is likely to promote the onset and progression of OA.
The Ca 2þ -CaM signal also has a crucial function in maintaining the cartilage phenotype in response to mechanical stimuli in mature chondrocytes. Mechanical stimuli can change intracellular concentration of Ca 2þ in chondrocytes in seconds to minutes (20, 21) . Cyclic or dynamic loading stimulates the synthesis of cartilage extracellular matrix components (22, 23) . CaM is required for the transient elevation of Agc1 mRNA in bovine articular cartilage explants by lowlevel compressive loading (11) . These findings suggest that daily mechanical stimuli might maintain healthy articular cartilage via the Ca 2þ -CaM signaling mechanism. Therefore, aberration of this mechanism in articular chondrocytes would also eventually spur the onset and progression of OA.
The identity of downstream regulators of CaM in chondrocytes remains unclear. CaM might bind directly to SOX9, a key regulator of chondrogenesis, and facilitate its nuclear translocation (24) . CaM also could facilitate chondrogenesis through activating calcineurin, a Ca 2þ -CaM dependent phosphatase, which is involved in maintaining the chondrocyte phenotype (18) . Calcineurin also plays a role in the pathway mediating the transient elevation of Agc1 mRNA in response to low-level compressive loading in bovine articular cartilage explants (11) . The contribution of CaM-dependent protein kinase II in this pathway has also been established (11) . Further study is necessary to characterize the signaling pathway downstream of CaM. Clarification of CaM-mediated pathways would present a new paradigm for the etiology and pathogenesis of OA, as well as a new target for treatment of OA.
With regard to complex genetic traits, each related gene contributes disease susceptibility to some extent, but such genes may also interact with each other. Most recently, we have found ASPN as a susceptibility gene for both knee and hip OA (17) . Asporin is an extracellular matrix protein, which inhibits chondrocyte differentiation by binding TGFb1 and suppressing its signal. The combinatorial effect between CALM1 and ASPN found in this study suggests presence of the epistatic effect of the two loci. There may be a cross-talk between the TGF-b and CaM signals in chondrocyte. The relationship between CaM and asporin should be clarified in future work.
MATERIALS AND METHODS
Subjects
We recruited 428 individuals affected with hip OA (24 males and 404 females, mean age: 53.7 years) and 1008 controls (517 males and 491 females, mean age: 46.7 years) from several medical institutions in Japan. All subjects were Japanese. Most cases were female (94%). All individuals with hip OA were symptomatic and were treated in these medical institutions on a regular basis. Hip OA was diagnosed by clinical symptoms and radiological findings of narrowing of the joint space and/or osteophytes of the hip joint. Because acetabular dysplasia is the most common cause and predisposing factor of hip OA in Japan (25) , 40% of the cases had acetabular dysplasia (center-edge angle ,258 or acetabular angle .258 in the anteroposterior radiograph of the hip). We obtained informed consent from each subject as approved by the ethical committees of the participating medical institutions and the SNP Research Center of The Institute of Physical and Chemical Research (RIKEN). Genomic DNA was extracted from peripheral blood leukocytes of each subject, using a standard protocol.
Large-scale association study
For the association study, we used our own SNP database (JSNP database, http://snp.ims.u-tokyo.ac.jp/) and carried out screening of SNPs as described previously (9, 26) . First, we genotyped 81 398 SNPs in genomic DNA from 94 individuals with hip OA and 633 control individuals. For the successfully genotyped SNPs, we calculated P-values as previously described (the first screen) (9) . SNPs that passed the first screen were further genotyped in a second replication panel consisting of individuals with hip OA (334) and control (375) subjects, as an independent test. For both screens, P-values less than 0.01 were considered significant.
SNP discovery and genotyping
For a fine-scale association study and LD mapping of the 400 kb region containing CALM1, we detected SNPs in the region by direct sequencing of genomic DNA from 16 affected individuals as described previously (9, 26) . We genotyped the SNPs using the Invader assay, TaqMan assay and direct sequencing of PCR products with capillary sequencers (ABI3700, Applied biosystems) and tested for the association.
Statistical analysis
We carried out statistical analysis for the association study, Hardy -Weinberg equilibrium, calculation of LD coefficient (D 0 ) and LD index (D) as described previously (27, 28) . We estimated haplotype frequencies using the expectationmaximization algorithm (29) . We examined combinatorial effects of CALM1 and other loci with regard to OA susceptibility as previously described (27) . Odds ratio was defined against the genotype consisted of homozygotes of non-susceptibility alleles from both loci. Luciferase assay data were analyzed by Student's t-test using Excel software (Microsoft).
Luciferase assay
DNA fragments corresponding to the promoter and 5 0 -untranslated region of CALM1 (left panel in Fig. 2B ) were amplified by PCR using genomic DNA containing the 216T or 216C allele as template, then cloned into the Nhe IXho I sites of pGL3-basic (Promega) in the 5 0 -3 0 orientation. The primer sequences used for PCR are listed in Supplementary Material, Table S3 . We grew OUMS-27 and Huh-7 cells (JCBR cell bank, Osaka, Japan) in Dulbecco's Modified Eagle's medium (DMEM) (Sigma) supplemented with 10% FBS containing antibiotics (100 U/ml penicillin-G and 100 mg/ml streptomycin). We then transfected cells (5 Â 10 4 cells/well) with 0.2 mg of the constructs and 4 ng of pRL-TK vector (Promega) as an internal control for transfection efficiency, using Fugene-6 (Roche). After 24 h, cells were solubilized and luciferase activity was measured using the Pikkagene dual luciferase assay system (Toyo Ink, Tokyo, Japan).
Gel-shift assay
Nuclear extract was prepared from Huh-7 cells as previously described (30) . We incubated the nuclear extract with 34 bp double-strand oligonucleotide probes for the 216C and 216T alleles for 20 min at room temperature. Oligonucleotide sequences are listed in Supplementary Material, Table S4 . Probes were labeled using the digoxigenin gel-shift kit (Roche). For competition studies, we pre-incubated the nuclear extract with unlabeled oligonucleotides (125-fold excess) before adding labeled oligonucleotide. Protein -DNA complexes were separated by electrophoresis on a 6% polyacrylamide gel in 0.5Â TBE buffer, followed by transfer to nitrocellulose membrane and detection using a chemiluminescent signal detection system (Roche) according to the manufacturer's instructions.
RNA difference plot analysis
RNA difference plot analysis was performed as previously described (15) . The cDNA and genomic DNA from normal human articular chondrocytes (nHAC, Cambrex Corporate, East Rutherford, NJ, USA) were used as templates for PCR. Fragments containing þ114G or þ114A were amplified using specific primers listed in Supplementary Material, Table S5 . The 5 0 ends of the forward primers were labeled with Texas Red. PCR was carried out using AmpliTaq DNA polymerase (Applied biosystems) in 10 ml of reaction volume, followed by treatment with 0.5 U of Klenow fragment (Takara, Tokyo, Japan). For single-strand conformation polymorphism analysis, an aliquot was diluted with 10 volumes of a loading solution containing 90% deionized formamide and 0.01% fuchsin (Sigma), then denatured and applied to a 0.5Â MDE gel solution (Cambrex bio science Rockland, Inc., Rockland, ME, USA) containing 1 Â TBE. Electrophoresis was carried out at 208C and 30 W for 2 h using an SF5200 autosequencer (Hitachi Ltd, Tokyo, Japan). The signal intensity of the polymorphic fragments was analyzed using Allele Links (Hitachi Ltd). Experiments were repeated nine times independently. The expression ratio between two alleles was calculated by dividing the RNA ratio by the DNA ratio with confidence interval.
Chondrogenic differentiation of ATDC5 cells
A chondrogenic mouse embryonic carcinoma cell line, ATDC5 (RIKEN cell bank, Tsukuba, Japan), was maintained in a 1: 1 mixture of DMEM and Ham's F12 medium (DMEM/ F12, Invitrogen) supplemented with 5% FBS containing antibiotics (100 U/ml penicillin-G and 100 mg/ml streptomycin). Cells were plated at 3 Â 10 4 cells/well in 12-well plates. After cells reached confluence, the culture medium was replaced with differentiation medium (DMEM/F12 supplemented with 5% FBS, antibiotics, 10 mg/ml bovine insulin, 10 mg/ml human transferrin and 3 Â 10 28 M sodium selenite) in the presence (20 mM) or absence of the CaM inhibitor W-7 (Wako, Osaka, Japan) and cultured for several time periods (0, 6, 10, 14, 18 and 22 days). The culture medium was replaced every other day.
Ionomycin stimulation of RCJ3.1C5.18 cells RCJ3.1C5.18 cells were generously provided by Jane Aubin (University of Toronto) (31) . Cells were maintained in DMEM supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml). Cells were plated at 1 Â 10 5 cells/well in 12-well plates. After cells reached confluence, the culture medium was replaced with medium containing 2 mM ionomycin (Sigma) with or without various concentrations of W-7 and was cultured for an additional 24 h.
Quantitative real-time PCR analysis
We extracted total RNA from ATDC5 and RCJ3.1C5.18 cells and synthesized first-strand cDNA. We carried out real-time PCR on an ABI PRISM 7700 sequence detection system (Applied biosystems) using QuantiTect SYBR Green PCR (Qiagen) according to the manufacturer's instructions. Firststrand cDNA was amplified using primers specific for the mouse and rat a1 chain of the type II collagen (Col2a1 ) gene, the aggrecan 1 (Agc1 ) gene and rodent Gapdh (Applied biosystems). Copy numbers of Col2a1 and Agc1 were calculated by referring standard curves and normalized by the total RNA using Gapdh as an internal control. Specific primer sequences are listed in Supplementary Material, Table S6 .
